| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |